Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: Neuroendocrine evidence in normal and parkinsonian subjects

Psychoneuroendocrinology

Volumn 25, Issue 2, 2000, Pages 179-185

  Volpi, Riccardo ^a   Chiodera, Paolo ^a   Caffarra, Paolo ^a   Scaglioni, Augusto ^b   Malvezzi, Laura ^b   Saginario, Antonio ^c   Coiro, Vittorio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Fidenza Hospital   (Italy)

^c Hospital of Piacenza   (Italy)

Author keywords

Gamma hydroxybutyric acid; GH; Parkinson's disease

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALCOVER; GROWTH HORMONE; MUSCARINIC RECEPTOR; PIRENZEPINE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AREA UNDER CURVE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NEUROSECRETORY SYSTEMS; PARKINSON DISEASE; PIRENZEPINE; RECEPTORS, MUSCARINIC; SODIUM OXYBATE;

EID: 0033991369     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(99)00048-7     Document Type: Article

References (17)

1. Casanueva F.F., Villanueva L., Dieguez C., Cabranes J.A., Diaz Y., Szoke B., Scanlon M.F., Schally A.V. Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level. J. Clin. Endocrinol. Metab. 62:1986;186-191.
2. Coiro V., Volpi R., Dassó L., Marehesi C., Castelli A., Rossi G., Camellini L., Chiodera P. Cholinergic-muscarinic receptors do not mediate growth hormone release in response to baclofen, a γ-aminobutyric acid agonist, in humans. Horm. Metabol. Res. 17:1985;260-261.
3. Flock J., Acs Z., Makara G.B., Erdo S.L. Site of α-aminobutyric acid (GABA)-mediated inhibition of growth hormone secretion in the rat. Neuroendocrinology. 39:1984;510-516.
4. Gerra G., Marcato A., Fertonani Affini G., Avanzini P., Maestri D., Fontanesi B., Caccavari R., Delsignore R. Gamma hydroxybutiric acid (GHB) and neuroendocrine function in humans. Neuroendocrinol. Lett. 7:1994;55-63.
5. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
6. Hammer R., Koss F.W. The pharmacokinetic profile of pirenzepine. Scand. J. Gastroenterol. 14(Suppl. 57):1979;1-6.
7. Hoen M.M., Yahr M.D. Parkinsonism: onset progression and mortality. Neurology. 17:1967;427-441.
8. Massara F., Ghigo E., Goffi S., Molinatti G.M., Muller E.E., Camanni F. Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. J. Clin. Endocrinol. Metab. 59:1984;1025-1026.
9. Nishino N., Fujiwara H., Noguchi-Kuno S.A., Tanaka C. GABA A receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease. Jpn. J. Pharmacol. 48:1988;331-339.
10. Racagni G., Apud J.A., Cocchi D., Locatelli V., Muller E.E. GABAergic control of anterior pituitary hormone secretion. Life Sci. 31:1982;823-838.
11. Richardson S.B., Hollander C.S., D'Eletto R., Greenleaf P.W., Thaw C. Acetylcholine inhibits the release of somatostatin from the rat hypothalamus in vitro. Endocrinology. 107:1980;122-129.
12. Rinne J.O., Lonnberg P., Marjamak P., Rinne U.K. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease. Brain Res. 483:1989;402-406.
13. Snead O.C. Gamma hydroxybutyrate in the monkey. Neurology. 28:1978;636-642.
14. Spitzer R.L., Endicott J., Robins E. Research diagnostic criteria: rationale and reliability. Arch. Gen. Psychiatry. 35:1978;773-782.
15. Vijayan E.E., McCann S.M. Effects of intraventricular injection of gamma-aminobutyric acid (GABA) on plasma growth hormone and thyrotropin in conscious ovariectomized rats. Endocrinology. 103:1978;79-83.
16. Volpi R., Chiodera P., Caffarra P., Scaglioni A., Saccani A., Coiro V. Different control mechanisms of growth hormone (GH secretion between α-amino- and α-hydroxy-butyric acid: neuroendocrine evidence in Parkinson's disease. Psychoneuroendocrinology. 22:1997;531-538.
17. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67:1983;361-370.